Are you up to date on biosimilar best practices? Take our GI Pop Quiz!

Think you’ve mastered the best practices for switching to a biosimilar? Now’s your chance to find out. Test your knowledge with our new interactive course — GI Pop Quiz! Biosimilars in IBD — and sharpen your skills in navigating the evolving landscape of biosimilars in clinical practice. This quick, engaging session challenges you to think […]
Save your spot in two Gastro Bites sessions in November

Join us on Nov. 8 and Nov. 19 for a recap of UEGW research and a discussion on AI.
New guidance: When to use potassium-competitive acid blockers

Experts provide nine pieces of best practice advice for using potassium-competitive acid blockers (P-CABs) to treat acid-related ailments.
Most patients can continue GLP-1 anti-obesity drugs before surgery

New multi-society guidance provides clarity across GIs, surgeons and anesthesiologists.
AGA calls on FDA to retain access to conventional FMT
In addition to the new FDA-approved therapies, we still need access to conventional fecal microbiota transplantation for complicated and vulnerable patients with C. diff infection.
ABIM eliminates 2-year MOC point requirement
In response to feedback to reduce physician workload, this change will go into effect immediately.
Gut Microbiota for Health World Summit
Gain exclusive insights at the upcoming Gut Microbiota for Health World Summit.
Act now: DDW® 2025 abstract submission period closes Dec. 5
Present your research at the premier event in GI and hepatology! Submissions due Dec. 5.
Top reasons to serve on an AGA committee
Share your passion, ideas, and innovative thoughts by volunteering to serve as an AGA leader.
Unlock the latest clinical updates with the 2024 PG Course OnDemand
Access this new content before it’s too late!